[angioedema Related To The Use Of Streptokinase].

dc.creatorOliveira, Daniela Camargo de
dc.creatorCoelho, Otávio Rizzi
dc.creatorParaschin, Karen
dc.creatorFerraroni, Natasha Rebouças
dc.creatorZolner, Ricardo de Lima
dc.date2005-Aug
dc.date2015-11-27T13:02:21Z
dc.date2015-11-27T13:02:21Z
dc.date.accessioned2018-03-29T01:01:18Z
dc.date.available2018-03-29T01:01:18Z
dc.identifierArquivos Brasileiros De Cardiologia. v. 85, n. 2, p. 131-4, 2005-Aug.
dc.identifier0066-782X
dc.identifier/S0066-782X2005001400011
dc.identifierhttp://www.ncbi.nlm.nih.gov/pubmed/16113853
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/196380
dc.identifier16113853
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1296613
dc.descriptionAngioedema is a rare reaction to streptokinase, acute and potentially fatal, which should be quickly diagnosed and treated to guarantee the best prognosis for the patient. We describe here the case of a 65-year-old man, who displayed an anaphylactic reaction after the beginning of thrombolysis with streptokinase, which was quickly treated, and remained hospitalized for one week in the Intensive Care Unit.
dc.description85
dc.description131-4
dc.languagepor
dc.relationArquivos Brasileiros De Cardiologia
dc.relationArq. Bras. Cardiol.
dc.rightsaberto
dc.rights
dc.sourcePubMed
dc.subjectAged
dc.subjectAngioedema
dc.subjectElectrocardiography
dc.subjectFibrinolytic Agents
dc.subjectHumans
dc.subjectMale
dc.subjectStreptokinase
dc.title[angioedema Related To The Use Of Streptokinase].
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución